Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC Jan. 12, 2016 No Comments
ExCellThera cleared to begin phase I/II trial of ECT-100 for expansion of hematopoietic stem cells Dec. 23, 2015 No Comments
RSS